Keith Rubin
Impact in
- Microbiology top 2%
- Bacterial Infections and Vaccines
-
- Advanced Drug Delivery Systems
Papers in
- Microbiology 12
- Bacterial Infections and Vaccines 12
-
- Asthma and respiratory diseases 1
- Alzheimer's disease research and treatments 1
- Co-authors
- Steven Glazer (6 shared papers)Camille Locht (8 shared papers)Marcel Thalen (4 shared papers)Nathalie Mielcarek (2 shared papers)Anne‐Sophie Debrie (2 shared papers)Sophie Lecher (1 shared paper)James F. Papin (1 shared paper)Stephanie Noviello (5 shared papers)
- Journals
- Immunobiology (2 papers)Vaccines (2 papers)Journal of Clinical Investigation (1 paper)The Lancet (1 paper)Expert Opinion on Drug Delivery (1 paper)
- Partner nations
- FranceUnited KingdomUnited States
In The Last Decade
Keith Rubin
14 papers receiving 290 citations
Peers
Comparison fields: 5 of 34
- Microbiology 225
- Pharmaceutical Science 20
- Immunology 49
- Endocrinology 5
- Infectious Diseases 22
Countries citing papers authored by Keith Rubin
This map shows the geographic impact of Keith Rubin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keith Rubin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keith Rubin more than expected).
Fields of papers citing papers by Keith Rubin
This network shows the impact of papers produced by Keith Rubin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keith Rubin. The network helps show where Keith Rubin may publish in the future.
Co-authors
The 25 scholars most cited alongside Keith Rubin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 75 | |
| 2 | 2020 | 53 | |
| 3 | 2023 | 50 | |
| 4 | 2020 | 47 | |
| 5 | 2018 | 20 | |
| 6 | 2016 | 18 | |
| 7 | 2022 | 14 | |
| 8 | 2015 | 12 | |
| 9 | 2020 | 9 | |
| 10 | 2024 | 5 | |
| 11 | 2016 | 4 | |
| 12 | 2025 | 4 | |
| 13 | 2025 | 1 | |
| 14 | 2025 | 1 | |
| 15 | 2024 | 0 | |
| 16 | 2026 | 0 | |
| 17 | 2026 | 0 |
About Keith Rubin
Keith Rubin is a scholar working on Microbiology, Physiology, Gastroenterology, Urology and Neurology, having authored 17 papers that have together received 313 indexed citations. Recurring topics across this work include Bacterial Infections and Vaccines (12 papers), Asthma and respiratory diseases (1 paper), Alzheimer's disease research and treatments (1 paper), Neuroinflammation and Neurodegeneration Mechanisms (1 paper), Autism Spectrum Disorder Research (1 paper), Hair Growth and Disorders (1 paper), Multiple Sclerosis Research Studies (1 paper) and Celiac Disease Research and Management (1 paper). The work is most often cited by research in Microbiology (225 citations), Pharmaceutical Science (20 citations), Immunology (49 citations), Endocrinology (5 citations) and Infectious Diseases (22 citations). Keith Rubin has collaborated with scholars based in France, United Kingdom and United States. Frequent co-authors include Steven Glazer, Camille Locht, Marcel Thalen, Nathalie Mielcarek, Anne‐Sophie Debrie, Sophie Lecher, James F. Papin, Stephanie Noviello, Andrew R. GORRINGE and Qiushui He. Their work appears in journals such as Immunobiology, Vaccines, Journal of Clinical Investigation, The Lancet and Expert Opinion on Drug Delivery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.